Literature DB >> 26125600

A role for homologous recombination proteins in cell cycle regulation.

Kaja Kostyrko1, Sandra Bosshard, Zuzanna Urban, Nicolas Mermod.   

Abstract

Eukaryotic cells respond to DNA breaks, especially double-stranded breaks (DSBs), by activating the DNA damage response (DDR), which encompasses DNA repair and cell cycle checkpoint signaling. The DNA damage signal is transmitted to the checkpoint machinery by a network of specialized DNA damage-recognizing and signal-transducing molecules. However, recent evidence suggests that DNA repair proteins themselves may also directly contribute to the checkpoint control. Here, we investigated the role of homologous recombination (HR) proteins in normal cell cycle regulation in the absence of exogenous DNA damage. For this purpose, we used Chinese Hamster Ovary (CHO) cells expressing the Fluorescent ubiquitination-based cell cycle indicators (Fucci). Systematic siRNA-mediated knockdown of HR genes in these cells demonstrated that the lack of several of these factors alters cell cycle distribution, albeit differentially. The knock-down of MDC1, Rad51 and Brca1 caused the cells to arrest in the G2 phase, suggesting that they may be required for the G2/M transition. In contrast, inhibition of the other HR factors, including several Rad51 paralogs and Rad50, led to the arrest in the G1/G0 phase. Moreover, reduced expression of Rad51B, Rad51C, CtIP and Rad50 induced entry into a quiescent G0-like phase. In conclusion, the lack of many HR factors may lead to cell cycle checkpoint activation, even in the absence of exogenous DNA damage, indicating that these proteins may play an essential role both in DNA repair and checkpoint signaling.

Entities:  

Keywords:  CHO cells; Fucci; cell cycle; homologous recombination repair; siRNA

Mesh:

Substances:

Year:  2015        PMID: 26125600      PMCID: PMC4614994          DOI: 10.1080/15384101.2015.1049784

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  50 in total

1.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

2.  Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Authors:  Atsushi Shibata; Olivia Barton; Angela T Noon; Kirsten Dahm; Dorothee Deckbar; Aaron A Goodarzi; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

3.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Sonia Franco; Monica Gostissa; Melissa A Rivera; Arkady Celeste; John P Manis; Jan van Deursen; André Nussenzweig; Tanya T Paull; Frederick W Alt; Junjie Chen
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

Review 4.  Homologous repair of DNA damage and tumorigenesis: the BRCA connection.

Authors:  Maria Jasin
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

5.  MDC1 interacts with Rad51 and facilitates homologous recombination.

Authors:  Junran Zhang; Zhefu Ma; Alejandro Treszezamsky; Simon N Powell
Journal:  Nat Struct Mol Biol       Date:  2005-09-25       Impact factor: 15.369

6.  Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.

Authors:  L-C Hsu; X Huang; S Seasholtz; D M Potter; S M Gollin
Journal:  Oncogene       Date:  2006-04-17       Impact factor: 9.867

7.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

8.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

9.  RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation.

Authors:  Sophie Badie; Chunyan Liao; Maria Thanasoula; Paul Barber; Mark A Hill; Madalena Tarsounas
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

10.  Contrasting quiescent G0 phase with mitotic cell cycling in the mouse immune system.

Authors:  Michio Tomura; Asako Sakaue-Sawano; Yoshiko Mori; Mitsuyo Takase-Utsugi; Akihiro Hata; Kenji Ohtawa; Osami Kanagawa; Atsushi Miyawaki
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more
  9 in total

1.  Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway.

Authors:  Yue Luo; Hui Wang; Xipeng Zhao; Chao Dong; Fengmei Zhang; Gang Guo; Gongshe Guo; Xiaowei Wang; Simon N Powell; Zhihui Feng
Journal:  Toxicol Res (Camb)       Date:  2016-02-18       Impact factor: 3.524

2.  Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer.

Authors:  Dwight H Owen; Terence M Williams; Erin M Bertino; Xiaokui Mo; Amy Webb; Catherine Schweitzer; Tom Liu; Sameek Roychowdhury; Cynthia D Timmers; Gregory A Otterson
Journal:  Lung Cancer       Date:  2019-06-17       Impact factor: 5.705

3.  Overexpression of RAD51B predicts a preferable prognosis for non-small cell lung cancer patients.

Authors:  Mengyin Wu; Zufeng Sheng; Lingyan Jiang; Zhengyuan Liu; Yuhua Bi; Yueping Shen
Journal:  Oncotarget       Date:  2017-09-06

4.  Screening of Pesticides with the Potential of Inducing DSB and Successive Recombinational Repair.

Authors:  Karen Suárez-Larios; Ana-María Salazar-Martínez; Regina Montero-Montoya
Journal:  J Toxicol       Date:  2017-10-10

5.  Single-Cell Atlas of the Chinese Tongue Sole (Cynoglossus semilaevis) Ovary Reveals Transcriptional Programs of Oogenesis in Fish.

Authors:  Xiang Liu; Yingyi Huang; Fujian Tan; Hong-Yan Wang; Jian-Yang Chen; Xianghui Zhang; Xiaona Zhao; Kaiqiang Liu; Qian Wang; Shanshan Liu; Francesc Piferrer; Guangyi Fan; Changwei Shao
Journal:  Front Cell Dev Biol       Date:  2022-03-01

6.  Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy.

Authors:  Robert Fred Henry Walter; Claudia Vollbrecht; Robert Werner; Thomas Mairinger; Jan Schmeller; Elena Flom; Jeremias Wohlschlaeger; Nikolaos Barbetakis; Dimitrios Paliouras; Fotios Chatzinikolaou; Vasilis Adamidis; Kosmas Tsakiridis; Paul Zarogoulidis; Georgia Trakada; Daniel Christian Christoph; Kurt Werner Schmid; Fabian Dominik Mairinger
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207

7.  MAR-Mediated transgene integration into permissive chromatin and increased expression by recombination pathway engineering.

Authors:  Kaja Kostyrko; Samuel Neuenschwander; Thomas Junier; Alexandre Regamey; Christian Iseli; Emanuel Schmid-Siegert; Sandra Bosshard; Stefano Majocchi; Valérie Le Fourn; Pierre-Alain Girod; Ioannis Xenarios; Nicolas Mermod
Journal:  Biotechnol Bioeng       Date:  2016-10-03       Impact factor: 4.530

8.  Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.

Authors:  Chinnadurai Mani; Shirisha Jonnalagadda; Jojireddy Lingareddy; Sanjay Awasthi; William H Gmeiner; Komaraiah Palle
Journal:  Breast Cancer Res       Date:  2019-09-06       Impact factor: 6.466

9.  TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction.

Authors:  Christopher T Lux; Sowmya Pattabhi; Mason Berger; Cynthia Nourigat; David A Flowers; Olivier Negre; Olivier Humbert; Julia G Yang; Calvin Lee; Kyle Jacoby; Irwin Bernstein; Hans-Peter Kiem; Andrew Scharenberg; David J Rawlings
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.